TABLE 3

Outcomes for Baseline and Follow-up Planar Imaging and SPECT/CT in Oncology Cohort

Imaging typeIndeterminateBenignMalignantTotal
Baseline planar26 (52%)22 (44%)2 (4%)50
Follow-up planar7 (14%)20 (40%)23 (46%)50
Baseline5 (10%)17 (34%)28 (56%)50
SPECT/CT5 (10%)17 (34%)28 (56%)50
Follow-up SPECT/CT0 (0%)17 (34%)33 (66%)50